October 20, 2023

FastBack Bio

FastBack Bio is a biotechnology company with a novel CAR-T platform.Ā FastBack Bio will develop CAR-T therapeutics with a novel co-stimulatory domain, M83, from its in-licensed platform.

October 19, 2023


Promaxo develops and commercializes customer-centric MRI systems and MRI based technologies that enhance patients' lives and redefine the standard of care.

October 19, 2023


neuro42, Inc. is a medtech Company advancing futuristic technologies for screening, diagnosis, and targeted treatment of neurological conditions.

September 26, 2023


Kincell is a technology-forward contract development and manufacturing organization (CDMO).

September 26, 2023


Inceptor Bio is developing next-generation cell therapy programs with a focus on chimeric antigen receptor (CAR) constructs.

September 26, 2023


Experic is a CDMO and pharmaceutical supply services company.

September 26, 2023


eXmoor pharma is a one-stop cell and gene therapy partner accelerating the manufacturing journey from research to patients.

September 26, 2023


EnteroBiotix is a clinical-stage Microbiome biotech focused on developing therapeutics for Hepatic Encephalopathy and Graft vs. Host Disease.

September 26, 2023


DIANTĀ® Pharma Inc. was founded in 2019 and has developed continuous processing technology for nanoparticles.